Hemofiltration with the Seraph® 100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hemofiltration with the Seraph® 100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients

Published:2021-06-01 Issue:1 Volume:25 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

Kielstein Jan T.,Borchina Dan-Nicolae,Fühner Thomas,Hwang Soyoon,Mattoon Dawn,Ball Andrew J.

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

https://link.springer.com/content/pdf/10.1186/s13054-021-03597-3.pdf

Reference6 articles.

1. Shan D, Johnson JM, Fernandes SC, Suib H, Hwang S, Wuelfing D, Mendes M, Holdridge M, Burke EM, Beauregard K, et al. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection. Nat Commun. 2021;12(1):1931.

2. Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493.

3. Seffer MT, Cottam D, Forni LG, Kielstein JT: Heparin 2.0: a new approach to the infection crisis. Blood Purif 2020:1–7.

4. Kim SY, Jin W, Sood A, Montgomery DW, Grant OC, Fuster MM, Fu L, Dordick JS, Woods RJ, Zhang F, et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Antiviral Res. 2020;181:104873.

5. Pape A, Kielstein JT, Kruger T, Fuhner T, Brunkhorst R. Treatment of a critically Ill COVID-19 patient with the seraph 100 microbind affinity filter. TH Open. 2021;5(2):e134–8.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Seraph 100® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients;Antibodies;2024-08-06

2. Extracorporeal Removal of Viral and Bacterial Pathogens;Advances in Small Animal Care;2024-08

3. Extrakorporale Erregerelimination mit biomimetischem Adsorber – eine neue Therapiestrategie für die Intensivmedizin;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2024-07-10

4. Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID‐19 patients;Therapeutic Apheresis and Dialysis;2024-05-12

5. Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup;Nephrology Dialysis Transplantation;2024-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3